Axon Neuroscience Overview

  • Founded
  • 1999
Founded
  • Status
  • Private
  • Employees
  • 44
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $1.64M
Latest Deal Amount
  • Investors
  • 1

Axon Neuroscience General Information

Description

Developer of disease modifying immunotherapeutics designed to treat Alzheimer's disease. The company's immunotherapeutics focus to enhance the quality of life of patients suffering from Alzheimer's disease and Frontotemporal lobar degeneration, enabling physicians to begin treatment in early stage which results in successful cure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Arch. Makariou & 4 Arch. Makariou & Kalogreon4, Nicolaides Sea View City
  • Larnaca, 6016
  • Cyprus
+357 000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axon Neuroscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Mar-2003 $1.64M 00.000 Completed Generating Revenue
To view Axon Neuroscience’s complete valuation and funding history, request access »

Axon Neuroscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of disease modifying immunotherapeutics designed to treat Alzheimer's disease. The company's immunotherapeutic
Drug Discovery
Larnaca, Cyprus
44 As of 2021
00.000
0000000000 0 00.000

00000000

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
0000 000000000
Clarksville, MD
0 As of 0000
00.000
000000 0

00000 00

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000 000000000
Grand Rapids, MI
0 As of 0000
0000
0000 0000-00-00
000000&0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axon Neuroscience Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroNascent Venture Capital-Backed Clarksville, MD 0 00.000 000000 0
00000 000000000000 Formerly VC-backed Grand Rapids, MI 0 0000 000000&0 0000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 0000 00000000000 0000
0000000 Venture Capital-Backed Framingham, MA 00 000.00 0000000000 000.00
000000000 Venture Capital-Backed Milan, Italy 0 000.00 00000000000 000.00
You’re viewing 5 of 33 competitors. Get the full list »

Axon Neuroscience Executive Team (8)

Name Title Board Seat Contact Info
Michal Fresser Chief Executive Officer
Ladislav Satko Chief Financial Officer
Roman Sivak Managing Director
Norbert Zilka Ph.D Chief Science Officer
Martin Cabadaj Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Axon Neuroscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axon Neuroscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizonte Venture Management Asset Manager Minority 000 0000 000000 0
To view Axon Neuroscience’s complete investors history, request access »